SEC Form 4 reporting owner

Coughlin Timothy

Coughlin Timothy has filed 9 Form 4 transactions reported between May 11, 2026 and June 12, 2026, as a reporting owner of Travere Therapeutics, Inc., Director of Vir Biotechnology, Inc., Director of ADC Therapeutics SA and a reporting owner of aTYR PHARMA INC.

Name as filed: Coughlin Timothy

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$141K

1 lines

Companies

with Form 4 filings

Latest transaction

Jun 12, 2026

transaction date

Roles and reported holdings

TVTXTravere Therapeutics, Inc.
May 15, 2026 – Jun 12, 2026
Reporting owner
Held directly52,250 sh as of May 15, 2026 · Form 4
24 months: $141K sold
VIRVir Biotechnology, Inc.
Jun 9, 2026
Director
No common-stock holding reported on a purchase, sale, gift or withholding line.
ADCTADC Therapeutics SA
Jun 1, 2026 – Jun 3, 2026
Director
Held directly72,400 sh as of Jun 3, 2026 · Form 4
ATYRaTYR PHARMA INC
May 11, 2026
Reporting owner
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 9 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Jun 12, 2026	TVTX	Option exerciseCode M · direct	10,000	$26.52	$265K@ $26.52	66,250	Form 4
Jun 9, 2026	VIRDirector	Grant or awardCode A · direct	16,000	—	—	16,000	Form 4
Jun 9, 2026	VIRDirector	Grant or awardCode A · direct	8,000	—	—	8,000	Form 4
Jun 3, 2026	ADCTDirector	Shares withheld for tax or exercise priceCode F · direct	12,600	$3.08	$39K@ $3.08	72,400	Form 4
Jun 1, 2026	ADCTDirector	Grant or awardCode A · direct	45,000	—	—	85,000	Form 4
May 19, 2026	TVTX	Grant or awardCode A · direct	12,000	—	—	12,000	Form 4
May 19, 2026	TVTX	Grant or awardCode A · direct	4,000	—	—	56,250	Form 4
May 15, 2026	TVTX	Open-market saleCode S · direct	3,250	$43.49	$141K@ $43.49	52,250	Form 4
May 11, 2026	ATYR	Grant or awardCode A · direct	50,000	—	—	50,000	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.